| Literature DB >> 35152340 |
Ayman El Nakeeb1, Sameh Hany Emile2, Ahmed AbdelMawla2, Mohamed Attia2, Mohamed Alzahrani3, Ayman ElGamdi3, Abd Elwahab Nouh3, Abdulaziz Alshahrani3, Riyadh AlAreef3, Taha Kayed4, Hosam Mohamad Hamza4, Ahmad AlMalki5, Fares Rayzah5, Motaz Alsharif5, Fares Alsharif5, Mohammed M Mohammed4.
Abstract
BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic had a striking impact on healthcare services in the world. The present study aimed to investigate the impact of the COVID-19 pandemic on the presentation management and outcomes of acute appendicitis (AA) in different centers in the Middle East.Entities:
Keywords: Appendicitis; COVID-19; Multicenter; Outcome; Pandemic
Mesh:
Year: 2022 PMID: 35152340 PMCID: PMC8853311 DOI: 10.1007/s00384-022-04108-8
Source DB: PubMed Journal: Int J Colorectal Dis ISSN: 0179-1958 Impact factor: 2.796
Demographic data
| 608 (61.8%) | 376 (38.2%) | 0.19 | |
| 566 (58.9%) | 395 (41.1%) | ||
| 28.83 ± 12.75 (12–75) | 29.71 ± 11.7 (12–72) | 0.13 | |
| | 718 (61.2%) | 482 (62.5%) | 0.57 |
| | 456 (38.8%) | 289 (37.5%) | |
| | 1174 (100%) | 771 (100%) | 1 |
| | 646 (55%) | 403 (52%) | 0.23 |
| | 761 (64.8%) | 478 (62%) | 0.21 |
| | 848 (72.2%) | 521 (74.3%) | 0.13 |
| | 786 (65.4%) | 501 (65%) | 0.81 |
| 7.29 ± 1.44 (3–10) | 7.52 ± 1.53 (3–10) | 0.001 | |
| | 95 (8.1%) | 35 (4.5%) | |
| | 345 (29.4%) | 211 (27.4%) | 0.003 |
| | 734 (62.5%) | 525 (68.1%) | |
| 11.84 ± 11.85 (5–27) | 12.11 ± 3.47 (6–28) | 0.09 | |
| | 281 (23.9%) | 110 (14.3%) | |
| | 157 (13.4%) | 75 (9.7%) | 0.0001 |
| | 736 (62.7%) | 586 (76%) | |
| | 1061 (90.4%) | 663 (86%) | |
| | 113 (9.6%) | 108 (14%) | 0.02 |
| | 43 (3.7%) | 124 (16.1%) | |
| | 0.0001 | ||
| | |||
| 1131 (96.3%) | 647 (83.9%) |
Operative data of patients who underwent appendectomy
| | 636 (70.5%) | 266 (29.5%) | 0.0001 |
| | 495 (56.5%) | 381 (43.5%) | |
| 16.97 ± 10.53 | 19.9 ± 13.79 | 0.0001 | |
| | 1075 (95%) | 533 (82.4%%) | |
| | 30 (2.7%) | 65 (10%) | 0.0001 |
| | 26 (2.3%) | 49 (7.6%) | 0.0001 |
| | 1018 (90%) | 539(83.3%) | |
| | 0.02 | ||
| | 113 (10%) | 108 (16.7%) | |
| | 33 (2.9%) | 37 (5.7%) | |
| | 75 (6.6%) | 64 (9.9%) | |
| | 5 (0.44%) | 7 (10.8%) | |
| | 639 (56.5%) | 380 (58.7%) | |
| | 492 (43.5%) | 267 (41.3%) | 0.35 |
| | 95 (8.4%) | 73 (11.3) | 0.046 |
| | 68 | 55 | 0.11 |
| | 27 | 18 | 0.11 |
| | 392 (34.6%) | 190 (29.4%) | 0.0001 |
| | 76 (6.7%) | 49 (7.6%) | |
| | 42 (3.7%) | 33 (5.1%) | |
| | 621 (54.9%) | 375 (58%) | |
| 136 (12%) | 114 (17.6%) | 0.001 | |
| 46.75 ± 8.34 (30–85) | 47.38 ± 9.37 (30–90) | 0.14 |
Fig. 1Clinical presentations in COVID period and pre-COVID period
Fig. 2Flow chart for management of patients with AA in COVID period and pre-COVID period
Outcome of surgical treatment
| 2.9 ± 2.18 (1–25) | 3.57 ± 4.06 (1–28) | 0.0001 | |
| 66 (5.8%) | 73 (11.3%) | 0.0001 | |
| | 26 (2.3%) | 8 (1.2%) | |
| | 30 (2.7%) | 39 (6%) | 0.0001 |
| | 10 (0.9%) | 26 (4%) | |
| | 0 | 0 | |
| 26 (2.3%) | 58 (9%) | 0.0001 | |
| | 21 | 36 | |
| | 5 | 22 | 0.05 |
| | 15 | 40 | 0..33 |
| | 11 | 18 | |
| | 22 | 36 | |
| | 4 | 11 | 0.05 |
| | 0 | 11 | |
| 26 (2.3%) | 32 (4.9%) | 0.003 | |
| 6 (0.5%) | 5 (0.8%) | 0.53 | |
| 6 (0.5%) | 16 (2.5%) | 0.0001 | |
| | 0 | 11 | 0.004 |
| | 6 | 5 | |
| 12 (1.1%) | 29 (4.5%) | 0.0001 | |
| 14 (1.2%) | 17 (2.6%) | 0.03 | |
| 7 (0.6%) | 5 (0.8%) | 0.7 | |
| 2 (0.2%) | 5 (0.8%) | 0.05 | |
| 15 (1.3%) | 19 (2.9%) | 0.02 | |
| | 6 | 7 | |
| | 3 | 5 | 0.9 |
| | 6 | 7 | |
| | 268 (23.7%) | 49 (7.6%) | |
| | 636 (56.2%) | 404 (62.4%) | 0.0001 |
| | 128 (11.3%) | 176 (27.2%) | |
| | 99 (8.8%) | 18 (2.8%) |
Fig. 3Surgical outcomes in COVID period and pre-COVID period
Univariate and multivariate analyses of complication occurrence
| | 831 (92.1%) | 71 (7.9%) | |||||
| | 808 (92.2%) | 68 (7.8%) | 0.93 | ||||
| 29 ± 12.4 | 29.61 ± 13.55 | 0.58 | |||||
| | 1338 (92.1%) | 114 (7.9%) | |||||
| | 215 (93.7%) | 17 (6.3%) | |||||
| | 50 (86.2%) | 8 (13.8%) | 0.16 | ||||
| | 1022 (91.9%) | 90 (8.1%) | |||||
| | 617 (92.6%) | 49 (7.4%) | 0.58 | ||||
| | 1065 (94.2%) | 66 (5.8%) | 0.0001 | 0.004 | 1.747 | 1.198 | 2.548 |
| | 574 (88.7%) | 73 (11.3%) | |||||
| 7.41 ± 1.36 | 7.49 ± 1.27 | 0.51 | |||||
| | 93 (92.1%) | 8 (7.9%) | |||||
| | 439 (93.8%) | 29 (6.2%) | 0.31 | ||||
| | 1107 (91.6%) | 102 (8.4%) | |||||
| | 1493 (92.8%) | 115 (7.2%) | 0.001 | 0.013 | Ref | ||
| | 78 (82.1%) | 17 (17.9%) | 0.024 | 3.139 | 1.161 | 8.494 | |
| | 68 (90.7%) | 7 (9.3%) | 0.006 | 2.307 | 1.272 | 4.186 | |
| | 1494 (92.9%) | 114 (7.1%) | 0.234 | Ref | |||
| | |||||||
| | 18 (90%) | 2 (10%) | 0.004 | 0.104 | 0.533 | 0.250 | 1.139 |
| | 118 (84.9%) | 21 (15.1%) | 0.583 | 0.615 | 0.108 | 3.488 | |
| | 9 (81.8%) | 2 (18.2%) | 0.341 | 2.150 | 0.445 | 10.839 | |
| 11.95 ± 3.33 | 12.26 ± 2.92 | 0.3 | |||||
| | 693 (91.3%) | 66 (8.7%) | 0.23 | ||||
| | 946 (92.8%) | 73 (7.2%) | |||||
| | 300 (94.6%) | 17 (12.2%) | 0.307 | 1.684 | 0.620 | 4.575 | |
| | 961 (92.4%) | 79 (7.6%) | 0.003 | 0.499 | 1.257 | 0.648 | 2.437 |
| | 266 (87.5%) | 38 (12.5%) | 0.509 | 1.164 | 0.742 | 1.828 | |
| | 112 (95.7%) | 5 (4.3%) | 0.748 | Ref | |||
| | 133 (79.2%) | 35 (20.8%) | 0.0001 | 0.002 | 7.486 | 2.146 | 26.118 |
| | 1506 (93.5%) | 104 (9.6%) | |||||
| | 1491 (93.3%) | 107 (6.7%) | 0.771 | Ref | |||
| | 108 (82.4%) | 23 (17.6%) | 0.0001 | 0.515 | 0.634 | 0.161 | 2.500 |
| | 40 (81.8%) | 9 (18.4%) | 0.965 | 0.980 | 0.403 | 2.384 | |
| 46.75 ± 8.54 | 49.68 ± 10.4 | 0.002 | 0.474 | 0.992 | 0.970 | 1.014 | |